Simpson Thacher Represents Underwriters in €3.6 Billion Senior Notes Offering and $7 Billion Senior Notes Offering by Takeda
07.20.20
This is only gets display when printing
Simpson Thacher recently represented the underwriters, led by Merrill Lynch International and Morgan Stanley & Co. International plc, in the SEC-registered offering by Takeda Pharmaceutical Company Limited (“Takeda”) of its €3.6 billion aggregate principal amount of Senior Notes. The Notes were issued in four series with maturities ranging from 2027 to 2040.
Simpson Thacher also represented the underwriters, led by BofA Securities, Inc. and Morgan Stanley & Co. LLC, in the SEC-registered offering by Takeda of its $7 billion aggregate principal amount of Senior Notes. The Notes were issued in four series with maturities ranging from 2030 to 2060.
Takeda intends to use the net proceeds from the offerings primarily to prepay borrowings under a syndicated term loan incurred in connection with the acquisition of Shire plc in 2019.
Takeda is a global, research and development-driven pharmaceutical company with a presence in more than 70 countries.
The Simpson Thacher team for the offerings included Alan Cannon, David Snowden and Yu Mizutani (Capital Markets); Jonathan Cantor (Tax); and Jennie Getsin (FINRA and Blue Sky).